1 Despite a growing body of evidence supporting vast clinical benefits of GLP-1s, 3 while results vary widely, one study showed that one-third of people stopped taking their GLP-1 in the first month, and less than half stayed on for more than 12 weeks
Kramer MS, Olivier M, McLean FH, Willis DM, Usher RH: Impact of intrauterine growth retardation and body proportionality on fetal and neonatal outcome
At Perfect B in Doral, those three factors are the starting point, not an afterthought
Warning signs that should prompt a clinical evaluation include: memory loss that disrupts daily life, increased difficulty planning or problem-solving, confusion about time or place, difficulty completing familiar tasks, changes in mood or personality, and withdrawal from social activities